FDA Approved: EPTIFIBATIDE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for the generic Eptifibatide from Mylan Institutional LLC. The approval updates the product's regulatory status and may …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Ischemic Heart Disease

Drugs mentioned

• EPTIFIBATIDE (EPTIFIBATIDE)

Snippet

SUPPL AP for EPTIFIBATIDE (EPTIFIBATIDE)